|
Hormone therapy after prostate cancer surgery improves survival for some patients
November 27, 2024
-
“These results suggest that some patients should be offered hormone therapy after surgery based on how likely it is that their cancer will spread."
|
|
Earlier use of bone-strengthening agents could benefit people with prostate cancer
September 20, 2024
-
“These bone-strengthening agents can decrease fracture rates and the need for radiation. We hope that this study will lead to earlier, more pro-active adoption.”
|
|
Researchers at The Ottawa Hospital awarded 14 CIHR grants worth more than $10 million
July 18, 2024
-
“Success at CIHR underscores the creativity, dedication and collaboration of our researchers and their teams. Funding for these innovative projects paves the way for groundbreaking advancement in biomedical sciences, improved patient care and progres
|
Show more news stories
|
|
New research reveals how immunotherapy drugs and viruses can work together to kill cancer cells
July 5, 2024
-
“These results will help guide ongoing efforts to combine checkpoint inhibitors with cancer-killing viruses in clinical trials."
|
|
New scientist profile: Dr. Nicola Schieda aims to improve imaging diagnosis of prostate, kidney cancers
October 5, 2022
-
Radiologist Dr. Nicola Schieda works on algorithms to improve the non-invasive diagnosis of kidney and prostate cancers using MRI and CT scans.
|
|
Researchers at The Ottawa Hospital awarded 18 CIHR grants worth more than $11 million
February 5, 2022
-
These projects will advance science and improve health in areas such as tuberculosis, blood disease, prostate cancer, heart disease, muscle repair, sleep apnea, brain cancer, medical imaging, virtual care, prehab, intellectual disability, sarcoma, CA
|
|
Bone-modulating drugs can be given less often during cancer treatment, reducing side-effects and saving time and money
November 28, 2020
-
When cancer spreads to the bones, it can cause pain, reduce mobility and increase the risk of fractures. Bone modulating drugs can help, but a new study suggests that to maximize the value of these drugs, it may be better to give them less often.
|
|
Prostate cancer study means more flexible treatment options for patients
January 23, 2020
-
A clinical trial led by Dr. Shawn Malone found that prostate cancer patients given hormone therapy prior to radiation therapy had similar outcomes compared with patients in whom both therapies were started simultaneously.
|
|
Dr. Dawn Stacey co-hosts International Shared Decision Making Conference
August 14, 2019
-
Dr. Dawn Stacey co-hosted the International Shared Decision Making Conference in Quebec City with Dr. France Légaré. More than 400 people from 22 countries participated in the conference, which focused on Patient-Oriented Shared Decision Ma
|
|
Clinicians at The Ottawa Hospital launch 14 innovative projects to improve health-care delivery, thanks to funding from TOHAMO and The Ottawa Hospital’s Research Institute
March 22, 2019
-
The Ottawa Hospital Academic Medical Organization (TOHAMO) has awarded $1.169 million in Innovation Grants to 14 teams, with supporting funds provided by the Ottawa Hospital Research Institute.
|
|
Advances in radiation therapy improve treatment for early-stage prostate cancer
January 16, 2019
-
Many patients with early-stage prostate cancer now have access to shorter and more convenient courses of radiation treatment thanks in part to research at The Ottawa Hospital. The treatment, known as hypofractionated radiation therapy, delivers more
|
|
Urologists reduce unnecessary prostate cancer surgery in Eastern Ontario
July 5, 2018
-
A growing number of patients in Eastern Ontario are being saved from unnecessary prostate cancer surgeries, according to a study led by Dr. Luke Lavallée and Dr. Luke Witherspoon published in CMAJ Open. While prostate cancer is the most common cancer
|
|
Prostate cancer research gets $200,000 boost from TELUS Ride For Dad
September 21, 2016
-
Drs. Christina Addison, Kristopher Dennis, Jim Dimitroulakos and Luke Lavallée were awarded a combined $200,000 from the 2015 TELUS Ride For Dad to study prostate cancer from four different angles. Dr. Lavallée will establish an advanced prostate
|
|
Immediate hormone therapy for prostate cancer is better than delayed: study
September 7, 2016
-
An international research team found that men with recurrent prostate cancer who received hormone treatment immediately had improved survival compared to those who delayed treatment. For many years doctors have puzzled over the best time to start a
|
|
To treat, or not to treat? How one man decided to keep his prostate cancer
June 29, 2016
-
Stephen Wilson of Iroquois, Ontario avoided unnecessary treatments and side-effects by opting for regular monitoring of his slow-growing prostate cancer.
Dairy plant manager Stephen Wilson faced a tough choice. In December 2012, he had just be
|
|
Virus vs. Prostate Cancer: Canadian Researchers Pioneer Next-generation Therapy
-- Prostate Cancer Canada and the Movember Foundation partner to make innovative work possible
September 30, 2015
-
A multi-disciplinary team of scientists and clinicians led by Dr. John Bell of The Ottawa Hospital is developing a treatment for prostate cancer using viruses that destroy cancer cells and boost the anti-cancer immune response, all the while leaving
|